Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.

about

Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.

Item

http://www.wikidata.org/entity/Q38703728

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Demonstration of a potent RET ...... on an ellipticine derivative.

@en

type

Item

label

Demonstration of a potent RET ...... on an ellipticine derivative.

@en

prefLabel

Demonstration of a potent RET ...... on an ellipticine derivative.

@en

P1476

Demonstration of a potent RET ...... on an ellipticine derivative.

@en

P2093

Daekyu Sun

http://www.w3.org/2001/XMLSchema#string

Vishnu Muthuraj Kumarasamy

http://www.w3.org/2001/XMLSchema#string

P2860

Quadruplex DNA: sequence, topology and structure

Crystal structure of parallel quadruplexes from human telomeric DNA

Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site

Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains

Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription

Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade

RNA interference: biology, mechanism, and applications

ret transforming gene encodes a fusion protein homologous to tyrosine kinases

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents.

P304

145-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/IJO.2017.3994

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28498409

http://www.w3.org/2001/XMLSchema#string

P932

5467785

http://www.w3.org/2001/XMLSchema#string